School of Medicine
Showing 1-10 of 937 Results
Alistair Aaronson, MD
Adjunct Clinical Assistant Professor, Medicine
Bio Courses Taught through SHIELD (Stanford Healthcare Innovations and Experiential Learning Directive):
A Patient Centered Exploration of Health and the Health Care System
INDE 290B, INDE 290C, PAS 280B, PAS 280C
This elective course for first year medical students explores challenges that patients face regarding the management of optimal health in a complex health care system. Specific topics include national healthcare reform, health economics and financing, social determinants of health, medication reconciliation, transitions of care, and the hospital discharge process.
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
Bio Dr. Fahim Abbasi specializes in diagnosis and treatment of prediabetes and insulin resistance. Dr. Abbasi has a special interest in prevention of diabetes and cardiovascular disease through lifestyle modifications.
Oscar J. Abilez
Instructor, Medicine - Cardiovascular Medicine
Current Research and Scholarly Interests Dr. Abilez' interests are aimed at elucidating how various biophysical and biochemical perturbations regulate early cardiovascular development across time and length scales that span several orders of magnitude, using human pluripotent stem cells as a model system.
Nadeem Elias Abou-Arraj
Clinical Instructor, Medicine
Bio Nadeem is a Lebanese-American born and raised in Toledo, Ohio. He earned his Bachelor of Arts in History from Harvard University and MD from Boston University School of Medicine. He completed Internal Medicine Residency in the Global Health track at Stanford University School of Medicine and is now a Clinical Instructor in Stanford's Department of Medicine, Division of Hospital Medicine. He is also pursuing a Master of Public Health at Berkeley in preparation for a career in Primary Care and Population Health. His goals are to assist patients with living healthy lifestyles and managing complex medical conditions, to improve health equity for underserved populations domestically and globally, focusing on immigrants and refugees, and to promote care based on a comprehensive understanding of social determinants of health.
Alyce Sophia Adams
Stanford Medicine Innovation Professor and Professor of Epidemiology and Population Health and of Medicine (Primary Care and Outcomes Research)
Bio Dr. Adams is the inaugural Stanford Medicine Innovation Professor and Professor of Epidemiology and Population Health and of Medicine (Primary Care and Outcomes Research), as well as Associate Director for Health Equity and Community Engagement in the Stanford Cancer Institute. Focusing on racial and socioeconomic disparities in chronic disease treatment outcomes, Dr. Adams' interdisciplinary research seeks to evaluate the impact of changes in drug coverage policy on access to essential medications, understand the drivers of disparities in treatment adherence among insured populations, and test strategies for maximizing the benefits of treatment outcomes while minimizing harms through informed decision-making. Prior to joining Stanford School of Medicine, Dr. Adams was Associate Director for Health Care Delivery and Policy and a Research Scientist at the Kaiser Permanente Division of Research, as well as a Professor at the Bernard J. Tyson Kaiser Permanente School of Medicine. From 2000 to 2008, she was an Assistant Professor in the Department of Population Medicine (formerly Ambulatory Care and Prevention) at Harvard Medical School and Harvard Pilgrim Health care. She received her PhD in Health Policy and an MPP in Social Policy from Harvard University. She is Vice Chair of the Board of Directors for AcademyHealth and a former recipient of the John M. Eisenberg Excellence in Mentoring Award from Agency for Healthcare Research and Quality and an invited lecturer on racial disparities in health care in the 2014/2015 National Institute of Mental Health Director?s Innovation Speaker Series.
Saul A. Rosenberg, MD, Professor of Lymphoma
Current Research and Scholarly Interests Clinical investigation in Hodgkin's disease, non-Hodgkin's Lymphomas and cutaneous lymphomas. Experimental therapeutics with novel chemotherapy and biologically targeted therapies.
The research program is highly collaborative with radiation oncology, industry, pathology and dermatology.